E-LIB Suche - Ergebnisse für: Ferrara, R.

1

118P Role of PD-L1 and pathological complete response (pCR)..:

Nuccio, A. ; Viscardi, G. ; Cameron, R....
ESMO Open. 9 (2024) - p. 102697 , 2024

Link: https://doi.org/10.1016/..

2

86P Artificial intelligence tools to predict early progress..:

Ogliari, F.R. ; Traverso, A. ; Barbieri, S....
ESMO Open. 9 (2024) - p. 102665 , 2024

Link: https://doi.org/10.1016/..

3

Tumor mutational burden for the prediction of PD-(L)1 block..:

Wang, X. ; Lamberti, G. ; Di Federico, A....
Annals of Oncology. 35 (2024) 6 - p. 508-522 , 2024

Link: https://doi.org/10.1016/..

4

127P Waning effect of adjuvant EGFR TKIs in resected EGFR-m..:

Imbimbo, M. ; Occhipinti, M. ; Simeon, V....
ESMO Open. 9 (2024) - p. 102920 , 2024

Link: https://doi.org/10.1016/..

5

55P EGFR variant allele frequency (VAF) impacts on metastat..:

Riva, S.T. ; Ogliari, F.R. ; Cangi, M.G....
ESMO Open. 8 (2023) 1 - p. 101865 , 2023

Link: https://doi.org/10.1016/..

6

33P Real-world experience of MET TKI-induced peripheral ede..:

Ferrara, R. ; Vansteenkiste, J.F. ; Yang, X....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S59-S60 , 2023

Link: https://doi.org/10.1016/..

7

Does right ventricular remodeling in elite athletes persist..:

Prosperi, S ; Monosilio, S ; Ferrara, R...
European Journal of Preventive Cardiology. 30 (2023) Supplement_1 - p. , 2023

Link: https://doi.org/10.1093/..

8

Polymyositis following varicella and mumps infection in adu..:

Masini, F. ; Gjeloshi, K. ; Pinotti, E....
Reumatismo. 75 (2023) 4 - p. , 2023

Link: https://doi.org/10.4081/..

9

P1.28-08 Definition of Resectable Stage III Non-Small Cell ..:

Xenophontos, E. ; Giaj Levra, N. ; Durieux, V....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S292 , 2023

Link: https://doi.org/10.1016/..

10

EP14.01-05 Neo-Adjuvant Immunotherapy in Malignant Pleural ..:

Novellis, P. ; Rossetti, F. ; Di Fonzo, R....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S713-S714 , 2023

Link: https://doi.org/10.1016/..

11

EP08.01-006 Using Real World data to build effective predic..:

prelaj, A. ; Galli, E.G. ; Pesenti, M....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S337-S338 , 2022

Link: https://doi.org/10.1016/..

12

MA10.07 Phase II Trial of Sunitinib in Patients with Type B..:

Proto, C. ; Galli, G. ; Manglaviti, S....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S79-S80 , 2022

Link: https://doi.org/10.1016/..

13

Levodopa-dependent differences in the non-oscillatory activ..:

, In: 2022 44th Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC),

Ferrara, R. ; Bianchi, AM. ; Priori, A... - p. 2310-2313 , 2022

Link: https://doi.org/10.1109/..

14

PEOPLE (NCT03447678), a first-line phase II pembrolizumab t..:

Lo Russo, G. ; Sgambelluri, F. ; Prelaj, A....
ESMO Open. 7 (2022) 6 - p. 100645 , 2022

Link: https://doi.org/10.1016/..

15

P1.15-02 Plasma microRNAs Modulation in Advanced NSCLC Pati..:

Proto, C. ; Chiaruttini, M.V. ; Prelaj, A....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S119-S120 , 2022

Link: https://doi.org/10.1016/..